Tag: Kazakhstan

Kazakhstan makes savings of 18 billion tenge on procurement of medicines

The authorities in Kazakhstan managed to save more than 18 billion tenge on procurement of drugs for the guaranteed amount of free medical care. This was announced by the Minister of Health Elzhan Birtanov.

Ministry will extend range of acquired goods from Kazakhstani manufacturers

The single distributor will extend the range of medicines acquired from Kazakhstani pharmaceutical companies, reports the Health Ministry of Kazakhstan.

First registrations of drugs under EAEU rules will take place in Kazakhstan

The pharmaceutical companies select the Republic of Kazakhstan as the reference country for registration of their products under the common market rules.

State regulation of prices for prescription drugs in Kazakhstan will start in October 2018

The analysis of the drug market in Kazakhstan revealed the shortcomings in procedures for the procurement of medicinal products, the facts of unjustified prescription of certain medicines by healthcare professionals.

Polpharma will invest 37 million dollars in Kazakhstan company Khimpharm

The key objectives for the fourth stage of the investment program implemented by Polpharma, an international group of companies, in 2018 – 2022 include the investments of 37 million dollars in the mod...

New GxP Club will implement good pharmaceutical practices in Kazakhstan

pharma manufacturing
The decision to establish specialized Kazakhstan GxP Club to bring together consultants involved in implementing good pharmaceutical practices was made earlier this year

Kazakhstan reaches important milestone of its National Drug Policy development

At the end of 2017, the Minister of Health of the Republic of Kazakhstan signed the order approving the Kazakhstan National Formulary

Kazakhstan signs direct contracts with 22 foreign drug manufacturers

sk pharmacy
22 foreign pharmaceutical manufacturers will supply 90 medicinal products to Kazakhstan under direct contracts with SK-Pharmacy

Three pharmaceutical plants in Kazakhstan will manufacture 19 insulins

Karaganda Pharmaceutical Complex, Hikma CIS and Eleas plan to start producing 19 insulins under the long-term contracts with SK-Pharmacy

Guaranteed state order can drive the development of pharma cluster in Astana

The guaranteed state order for pharmaceutical products will become a significant driver for the development of pharmaceutical cluster in Astana

Pharma manufacturers of Kazakhstan sign a Code for Ethical Promotion of Medicines

An official ceremony of signing the Code for Ethical Promotion of Medicines was held on December 8, 2017 in Almaty

Oasmia Pharma’s cancer drug received marketing approval in Kazakhstan

Oasmia Pharmaceutical announced that it has received marketing approval for Paclical in Kazakhstan

Investment agreements were signed to develop Astana pharmaceutical cluster

The Akimat of Astana signed a number of memorandums and agreements in the total amount of 100 billion tenge for the development of pharmaceutical cluster

Scientists in Kazakhstan developed a novel antifungal medicine

The first locally developed novel broad-spectrum medicine for the treatment of fungal skin diseases was created in Kazakhstan

Kazakhstan’s Center for Expertise of Medicines joined IPRF and IGDRP

kazakhstan drug quality control
The meetings of the Management Committee of IPRF and the Steering Committee of IGDRP approved the admission of the Kazakhstan’s Center to IPRF and IGDRP

Production of two biotech drugs was launched in Karaganda

The plant of Karaganda Pharmaceutical Complex LLP began to produce two biotech drugs, such as Rituximab and Semiclotin